Skip to content
ClinCalc Pro
Menu
cardiology emergency

Steinhart Model for Acute Heart Failure in Undifferentiated Dyspnoea

Clinical prediction rule developed in the emergency department to diagnose acute heart failure (AHF) in adults presenting with acute dyspnoea when BNP is unavailable. Based on history and physical examination.

Used in: Heart Failure

Score interpretation

AHF Unlikely (< 15%) -- Evaluate for Alternative Diagnoses 0–5

Steinhart < 6 -- acute heart failure unlikely; other causes of dyspnoea should be pursued

→ Consider alternative diagnoses: AECOPD/asthma (salbutamol 5 mg nebulised, ipratropium 0.5 mg, prednisolone 40 mg); pulmonary embolism (Wells score, D-dimer, CTPA if indicated); pneumonia (CURB-65, antibiotic based on severity); pneumothorax (CXR, needle decompression); anaemia (FBC, transfusion if haemodynamically compromised); BNP/NT-proBNP to supplement clinical assessment; echocardiography if clinical uncertainty.

AHF Moderate Probability (~30-60%) -- Further Workup Required 6–10

Steinhart 6-10 -- moderate probability; AHF workup alongside alternative diagnoses

→ Urgent BNP or NT-proBNP; echocardiogram (bedside POCUS for B-lines, LV function, IVC); ECG (AF, LBBB, ischaemia); CXR (if not done); ABG; FBC, U+E, troponin; if BNP elevated: treat as AHF; furosemide 40-80 mg IV; oxygen if SpO2 < 94%; CPAP/NIV if severe (CPAP 5-10 cmH2O); sitting position; BP management; refer cardiology.

AHF Likely (> 80%) -- Initiate AHF Treatment 11–17

Steinhart > 10 -- acute heart failure highly likely; begin AHF treatment immediately

→ Immediate AHF management: oxygen if SpO2 < 90%; CPAP (PEEP 5-10 cmH2O) if respiratory distress -- CPAP-AHF trial: reduces intubation; furosemide IV 40-80 mg (or 1-2.5x regular oral dose if already on furosemide); GTN infusion if SBP > 110 mmHg (20-200 mcg/min titrated for dyspnoea relief); morphine with caution (recent data suggest caution -- may worsen outcomes); Foley catheter for urine output monitoring (target > 0.5 mL/kg/hour); BNP-guided therapy; echocardiogram for EF; consider ARNI/SGLT2i optimisation; cardiogenic shock triggers (MAP < 65, cold peripheries, UO < 0.5 mL/kg/h): vasopressor and MCS assessment.

Interpretation bands for the Steinhart AHF Model. Apply clinical judgement and local guidance.

References

Related

Curated clinical cross-links plus same-class fallbacks.

Decision support only — verify against a current formulary, NICE, or your local guideline before clinical use.